Search

everythinglearnresearchcommunity

for

Search:↓

Ritlecitinib effectively reduces severe hair loss in alopecia areata over 24 months.

Sintilimab with chemotherapy improves survival and response in advanced lung cancer but increases some side effects.

Gefitinib can cause rare scarring hair loss.

Ritlecitinib effectively treats alopecia areata with manageable side effects.

Ritlecitinib is a new treatment for severe hair loss in people 12 and older.

Ritlecitinib is generally safe for long-term use, with mostly mild side effects.

Merremia peltata leaf extract, particularly the bufotalinin compound, shows potential for treating hair loss.

Tofacitinib taken by mouth helps treat hair loss in children.

Ritlecitinib is effective and safe for treating severe alopecia areata in people aged 12 and older.

Ruxolitinib cream may help treat severe hair loss in children.

Ablative fractional laser treatment nearly matches the gene reduction effects of topical vismodegib in skin cancer.

Fisetin, found in fruits and vegetables, may help treat various health conditions like inflammation, diabetes, heart issues, cancer, and hair loss.

Ritlecitinib shows promise for hair regrowth in alopecia areata patients.

ONO-3403 effectively reduces mouse skin tumor growth without side effects.

Ritlecitinib and baricitinib are similarly effective for hair regrowth in severe alopecia areata.

Sonidegib and vismodegib have different side effects and reporting patterns.

INTASYL is a promising, adaptable RNAi technology for treating skin cancers.

Upadacitinib improved multiple immune-related conditions in one patient.

Erlotinib can cause hair loss and scalp issues, which improve after stopping the drug.

The treatment was ineffective in humans.

An 84-year-old man developed a rare scalp condition from a cancer drug but continued treatment as it was otherwise well tolerated.

Tofacitinib improved arthritis and partially improved hair loss in a lupus patient without side effects.

Ritlecitinib is effective for long-term hair regrowth in alopecia areata, especially in females and early treatment.

Ritlecitinib effectively regrows scalp, eyebrow, and eyelash hair in Asians with alopecia areata and is safe.

Some leukemia treatments can cause skin reactions similar to keratosis pilaris.

Gefitinib can cause skin problems, diarrhea, and nausea, but rarely causes severe lung disease or hair loss.

Baricitinib is effective and cost-efficient for treating severe alopecia areata in adults.

Ritlecitinib is effective and safe for treating alopecia areata, promoting significant hair regrowth.